Illegal cannabis grows are often hidden within US national forests, where they wreak damage on the local wildlife.
The year posed many challenges, but cannabis businesses, research centers, and reform groups still managed to make impressive headway. Analytical Cannabis looks back on the stories and issues that dominated the cannabis industry in 2021.
Kimberly Ross of Peak Compliance Labs outlines the many obstacles hemp faces before it becomes fully regulated in the US.
The recommendations have largely been welcomed by many in the UK’s CBD industry.
Participants in ayahuasca ceremonies report reductions in stress, anxiety, and depression whether they are given ayahuasca or not, a placebo-controlled study from researchers at Maastricht University has found.
Pfizer is set to acquire Arena Pharmaceuticals, a San Diego-based company currently developing a cannabinoid therapeutic called Olorinab.
The cannabis crop’s natural ability to accumulate heavy metal elements from the soil can pose a threat to the health of consumers, according to a new scientific review.
The new study from researchers at the University of Toronto suggests that cannabis users are more likely to sleep too little or too much than non-users.
The authors are now calling for further studies into the benefits of whole-plant cannabis medicines.